DePrince Race & Zollo Inc (DRZ)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,651,087
Closed -$69.3M 197
2025
Q1
$69.3M Sell
4,651,087
-78,171
-2% -$1.2M 1.44% 6
2024
Q4
$70.6M Buy
4,729,258
+308,267
+7% +$5.02M 1.4% 7
2024
Q3
$84.6M Buy
4,420,991
+999,288
+29% +$20.7M 1.62% 6
2024
Q2
$70.8M Buy
3,421,703
+216,907
+7% +$4.31M 1.58% 3
2024
Q1
$60.3M Buy
3,204,796
+1,874,809
+141% +$32.2M 1.3% 10
2023
Q4
$19.2M Buy
+1,329,987
New +$18.1M 0.43% 112

Other funds holding OGN

DePrince Race & Zollo Inc (DRZ)'s OGN Position: Q2 2025 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 4,651,087 shares — an estimated $69.3M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in OGN in Q4 2023 and held it in 6 quarters. The position peaked at $84.6M in Q3 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 4,651,087 Organon & Co shares in Q2 2025, an estimated $69.3M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Organon & Co in Q4 2023 and held it in 6 quarters.
  • DePrince Race & Zollo Inc (DRZ)'s Organon & Co position peaked at $84.6M in Q3 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q2 2025, filed 14 Aug 2025.